Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli ... Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program. 1 Lilly also reduced the ...

Eli Lilly announced Tuesday that it is selling higher-dose vials of Zepbound at lower prices in its direct-to-consumer program. The program offers self-administered vials for people whose insurance ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Eli Lilly and Company announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Programme. Lilly also reduced the ...